Search Results

Influenza Antiviral Therapeutics (Supplementry Material)

Author: Mayburd, Anatoly L.

Source: Recent Patents on Anti-Infective Drug Discovery, Volume 5, Number 1, January 2010 , pp. 64-75(12)

Publisher: Bentham Science Publishers

Multidrug resistance-associated proteins and implications in drug development

Authors: Liu, Ya-He; Di, Yuan-Ming; Zhou, Zhi-Wei; Mo, Sui-Lin; Zhou, Shu-Feng

Source: Clinical and Experimental Pharmacology and Physiology, Volume 37, Number 1, January 2010 , pp. 115-120(6)

Publisher: Blackwell Publishing

Defective interfering viruses and their potential as antiviral agents

Authors: Marriott, A. C.; Dimmock, N. J.

Source: Reviews in Medical Virology, Volume 20, Number 1, January 2010 , pp. 51-62(12)

Publisher: John Wiley & Sons, Ltd.

2-Arylbenzimidazoles as Antiviral and Antiproliferative Agents-Part 2

Authors: Vitale, Gabriella; Corona, Paola; Loriga, Mario; Carta, Antonio; Paglietti, Giuseppe; Colla, Paolo L.; Busonera, Bernardetta; Marongiu, Esther; Collu, David; Loddo, Roberta

Source: Medicinal Chemistry, Volume 5, Number 6, November 2009 , pp. 507-516(10)

Publisher: Bentham Science Publishers

5-fluorouracil in lethal mutagenesis of foot-and-mouth disease virus

Authors: Agudo, Rubén; Arias, Armando; Domingo, Esteban

Source: Future Medicinal Chemistry, Volume 1, Number 3, June 2009 , pp. 529-539(11)

Publisher: Future Science

Hepatitis B therapies and antiviral resistance detection and management

Authors: Holness, Giselle; Carriero, Damaris C; Dieterich, Douglas T

Source: Expert Review of Gastroenterology and Hepatology, Volume 3, Number 6, December 2009 , pp. 693-699(7)

Publisher: Expert Reviews

8-Azapurine Nucleus: A Versatile Scaffold for Different Targets

Authors: Giorgi, I.; Scartoni, V.

Source: Mini Reviews in Medicinal Chemistry, Volume 9, Number 12, October 2009 , pp. 1367-1378(12)

Publisher: Bentham Science Publishers

Treatment Strategies to Minimize or Prevent Chronic Allograft Dysfunction in Pediatric Renal Transplant Recipients: An Overview

Authors: Höcker, Britta; Tönshoff, Burkhard

Source: Pediatric Drugs, Volume 11, Number 6, 1 December 2009 , pp. 381-396(16)

Publisher: Adis International

Anti-influenza therapy: the emerging challenge of resistance

Author: Ison, Michael G

Source: Therapy, Volume 6, Number 6, November 2009 , pp. 883-891(9)

Publisher: Future Medicine

Synthesis, antimicrobial and antiviral activity of substituted benzimidazoles

Authors: Sharma, Deepika; Narasimhan, Balasubramanian; Kumar, Pradeep; Judge, Vikramjeet; Narang, Rakesh; De Clercq, Erik; Balzarini, Jan

Source: Journal of Enzyme Inhibition and Medicinal Chemistry, Volume 24, Number 5, October 2009 , pp. 1161-1168(8)

Publisher: Informa Healthcare

Outcome of treatment of Epstein-Barr virus-related post-transplant lymphoproliferative disorder in hematopoietic stem cell recipients: a comprehensive review of reported cases

Authors: Styczynski, J.; Einsele, H.; Gil, L.; Ljungman, P.

Source: Transplant Infectious Disease, Volume 11, Number 5, October 2009 , pp. 383-392(10)

Publisher: Blackwell Publishing

Varicella zoster virus: review of its management

Authors: Mustafa, M. B.; Arduino, P. G.; Porter, S. R.

Source: Journal of Oral Pathology & Medicine, Volume 38, Number 9, October 2009 , pp. 673-688(16)

Publisher: Blackwell Publishing

The capsid protein of human immunodeficiency virus: molecular recognition and design of antiviral agents

Author: Neira, José L.

Source: FEBS Journal, Volume 276, Number 21, November 2009 , pp. 6097-6097(1)

Publisher: Blackwell Publishing

In vitro antifungal activity of 2-(2′-hydroxy-5′-aminophenyl)benzoxazole in Candida spp. strains

Authors: Daboit, Tatiane Caroline; Stopiglia, Cheila Denise Ottonelli; Carissimi, Mariana; Corbellini, Valeriano Antonio; Stefani, Valter; Scroferneker, Maria Lúcia

Source: Mycoses, Volume 52, Number 6, November 2009 , pp. 507-510(4)

Publisher: Blackwell Publishing

Antiviral Agents for Influenza: Molecular Targets, Concerns of Resistance, and New Treatment Options

Authors: Maltezou, Helen C.; Tsiodras, Sotirios

Source: Current Drug Targets, Volume 10, Number 10, October 2009 , pp. 1041-1048(8)

Publisher: Bentham Science Publishers

Editorial [Hot topic: Antiretroviral, Anti-Inflammatory and Dopaminergic Substances in the Treatment of HIV-Infection (Guest Editor: Gabriele Arendt)]

Author: Arendt, Gabriele

Source: Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry (Formerly Cu, Volume 8, Number 2, June 2009 , pp. 114-114(1)

Publisher: Bentham Science Publishers

The role of viruses in the development and exacerbation of atopic disease

Authors: Kumar, Amit; Grayson, Mitchell H.

Source: Annals of Allergy, Asthma and Immunology, Volume 103, Number 3, September 2009 , pp. 181-187(7)

Publisher: American College of Allergy, Asthma, & Immunology

Chronic hepatitis B and C: update on therapy

Authors: Gonzalez, Stevan A; Keeffe, Emmet B

Source: Future Virology, Volume 4, Number 5, September 2009 , pp. 437-452(16)

Publisher: Future Medicine

Prospects for future therapy of HCV infection

Authors: Sakamoto, Naoya; Wu, George Y

Source: Future Virology, Volume 4, Number 5, September 2009 , pp. 453-462(10)

Publisher: Future Medicine

High risk of hepatitis B-virus reactivation after hematopoietic cell transplantation in hepatitis B core antibody-positive patients

Authors: Matsue, Kosei; Aoki, Takatoshi; Odawara, Jun; Fujiwara, Hideaki; Iwama, Kan-ichi; Kimura, Shun-ichi; Yamakura, Masayuki; Takeuch, Masami

Source: European Journal of Haematology, Volume 83, Number 4, October 2009 , pp. 357-364(8)

Publisher: Blackwell Publishing